Overview

Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
0
Participant gender:
All
Summary
This trial evaluates whether long-term treatment with Genotropin normalizes final (adult) height in short children born small for gestational age
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Criteria
Inclusion Criteria:

- Participation in the 90-080 study

Exclusion Criteria:

- Any severe, acute or chronic disease

- Any other identifiable reason for short stature